Sign up for free insights newsletter
Alcon AG

Alcon AG

ALCUnited States

Need professional-grade analysis? Visit stockanalysis.com

$74.24
+0.80%
End of day
Market Cap

$38.65B

P/E Ratio

39.05

Employees

25,942

Dividend Yield

0.43%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.49-0.24-0.930.08-0.57
Calmar-1.85-0.26-0.760.04-0.60
Sharpe-1.09-0.17-0.690.06-0.42
Omega0.800.990.891.030.94
Martin-6.90-1.16-1.220.10-1.82
Ulcer4.163.5416.4415.0910.84

Alcon AG (ALC) Price Performance

Alcon AG (ALC) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at $74.24, up 0.80% from the previous close.

Over the past year, ALC has traded between a low of $72.05 and a high of $97.95. The stock has lost 19.7% over this period. It is currently 24.2% below its 52-week high.

Alcon AG has a market capitalization of $38.65B, with a price-to-earnings ratio of 39.05 and a dividend yield of 0.43%.

About Alcon AG

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$10.40B
EBITDA
$2.33B
Profit Margin
9.42%
EPS (TTM)
1.98
Book Value
45.20

Technical Indicators

52 Week High
$98.85
52 Week Low
$71.55
50 Day MA
$80.91
200 Day MA
$81.15
Beta
0.70

Valuation

Trailing P/E
39.05
Forward P/E
22.62
Price/Sales
3.72
Price/Book
1.71
Enterprise Value
$41.60B